Meth Bill Draft Offers Quicker Review of Pseudoephedrine Replacements
This article was originally published in The Tan Sheet
Cough/cold medications reformulated to exclude pseudoephedrine would receive expedited review by FDA under a provision included in a recent draft of the Combat Meth Act
You may also be interested in...
The growing trend of limiting pseudoephedrine accessibility in stores is driving an expanding market for nasal decongestant alternatives containing phenylephrine
A wave of decisions from leading OTC drug retailers to place pseudoephedrine solids behind the counter could provide momentum for a federal pseudoephedrine BTC bill
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC